Supply Chain Management

Suppliers of raw and manufactured materials to biotech and pharmaceutical companies and drug manufacturers are challenged with an increasing complexity of the material supply chain. This has in turn led to increasing difficulty in ensuring quality supply of materials and components, excipients, APIs, intermediates and finished goods. Furthermore, the integrity of the (temperature controlled) supply chain is being challenged by increasing sub-standard manufacturing, inadequate business and process controls, as well as complex storage, handling, and distribution activities. Furthermore, international counterfeiting remains a meaningful concern.

The Supply Chain Management Interest Group offers its members the opportunity to influence the suppliers of the pharmaceutical and biotech industry to develop requirements that meet the needs of the industry in the areas of material quality, continuous improvement efforts, supply chain security, temperature control and the digitalization of supplier/customer business partnerships. The Interest Group will use existing information gathered from PDA members, suppliers, other industry groups, and drug manufacturers to document and develop industry standards and best practices for suppliers,drug manufacturers, and their supply chain partners to meet customer and regulatory requirements globally.